Skip to content

Polomar Health Services, Inc.: 10-Q filed 2023-08-23

What Polomar Health Services, Inc. reported in its quarterly report filed 2023-08-23 (fiscal Q2 2023): 22 published measures, 60 facts as tagged in accession 0001663577-23-000441.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-23
Fiscal period
fiscal Q2 2023
Accession
0001663577-23-000441 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Polomar Health Services, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-30130,224USD
At 2022-12-31261,484USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-3014,027USD
At 2022-12-3174,715USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-30116,197USD
At 2023-03-31207,155USD
At 2022-12-31186,769USD
At 2022-06-30-51,604USD
At 2022-03-31-37,896USD
At 2021-12-31-35,646USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-90,958USD91
2023-01-01 to 2023-06-30-180,764USD181
2023-01-01 to 2023-03-31-89,806USD90
2022-04-01 to 2022-06-30-13,708USD91
2022-01-01 to 2022-06-30-15,958USD181
2022-01-01 to 2022-03-31-2,250USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-244,449USD181
2022-01-01 to 2022-06-30-12,249USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-06-3046,849USD181
2022-01-01 to 2022-06-3012,249USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-1,162,597USD
At 2022-12-31-981,833USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2023-06-30107,807,983shares91
2023-01-01 to 2023-06-30107,793,942shares181
2022-04-01 to 2022-06-30313,577shares91
2022-01-01 to 2022-06-30305,784shares181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-90,958USD91
2023-01-01 to 2023-06-30-180,764USD181
2022-04-01 to 2022-06-30-13,708USD91
2022-01-01 to 2022-06-30-15,958USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-30130,224USD
At 2022-12-31261,484USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-3014,027USD
At 2022-12-3174,715USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2023-06-3090,958USD91
2023-01-01 to 2023-06-30180,764USD181
2022-04-01 to 2022-06-3013,708USD91
2022-01-01 to 2022-06-3015,958USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-06-30108,564,879shares
At 2022-12-31107,582,614shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-06-3028,019USD
At 2022-12-31225,619USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-06-301,169,729USD
At 2022-12-311,023,476USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-06-30116,197USD
At 2022-12-31186,769USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-06-302,205USD
At 2022-12-315,865USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-90,958USD91
2023-01-01 to 2023-06-30-180,764USD181
2022-04-01 to 2022-06-30-13,708USD91
2022-01-01 to 2022-06-30-15,958USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-3090,958USD91
2023-01-01 to 2023-06-30180,764USD181
2022-04-01 to 2022-06-3013,708USD91
2022-01-01 to 2022-06-3015,958USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-01-01 to 2023-06-30110,192USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-3010,000USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-302,655USD181
2022-01-01 to 2022-06-303,709USD181

Inspect the source

Entity
Polomar Health Services, Inc. / CIK 0001265521
Captured
2026-09-20T07:47:26.457Z
SEC response SHA-256
b2bb864aee3291884dec8c553b186abaae72d959c3f62abb5e78d805ebc59d7b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001265521.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))